Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Andrew Mok maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and lowers the price target from $31 to $28.
Cantor Fitzgerald analyst Sarah James maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Neutral and lowers the price targe...
Barclays analyst Andrew Mok maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Equal-Weight and lowers the price target fro...
On October 30, 2025, Dr. Nasser Khan notified the Company of his resignation as Chief Operating Officer ("COO") of the ...
Acadia Healthcare Co (NASDAQ:ACHC) lowers FY2025 Adj EPS guidance from $2.45-$2.65 to $2.35-$2.45 vs $2.48 analyst estimate. Lo...
Acadia Healthcare Co (NASDAQ:ACHC) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of ...
